C Balotta
Overview
Explore the profile of C Balotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
696
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007-2014 period: A weighted analysis
Franzetti M, De Luca A, Ceccherini-Silberstein F, Spagnuolo V, Nicastri E, Mussini C, et al.
J Clin Virol
. 2018 Aug;
106:49-52.
PMID: 30075459
Background: Recent studies suggest that transmitted drug resistance (TDR) may be decreasing in latest years, likely because of the reduced frequency of acquired resistance. However, specific risk factors, geographical areas...
2.
Vinken L, Fransen K, Pineda-Pena A, Alexiev I, Balotta C, Debaisieux L, et al.
Virus Evol
. 2017 Aug;
3(Suppl 1).
PMID: 28845274
No abstract available.
3.
Hofstra L, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al.
Clin Infect Dis
. 2015 Dec;
62(5):655-663.
PMID: 26620652
Background: Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the choice of initial regimen....
4.
Franzetti M, Violin M, Casazza G, Meini G, Callegaro A, Corsi P, et al.
Clin Microbiol Infect
. 2011 Dec;
18(3):E66-70.
PMID: 22192680
We analysed the 12-week virological response to protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) therapy in 1108 patients carrying B or non-B human immunodeficiency virus (HIV)-1 subtypes with...
5.
Lai A, Riva C, Marconi A, Balestrieri M, Razzolini F, Meini G, et al.
HIV Med
. 2010 Apr;
11(9):593-602.
PMID: 20408891
Background: HIV-1 non-B subtypes have recently entered Western Europe following immigration from other regions. The distribution of non-B clades and their association with demographic factors, over the entire course of...
6.
Papagno L, Appay V, Sutton J, Rostron T, Gillespie G, Ogg G, et al.
Clin Exp Immunol
. 2002 Nov;
130(3):509-17.
PMID: 12452843
The mechanisms underlying non-progression in HIV-1 infection are not well understood; however, this state has been associated previously with strong HIV-1-specific CD8+ T cell responses and the preservation of proliferative...
7.
Bottarel F, Bonissoni S, Lucia M, Bragardo M, Bensi T, Buonfiglio D, et al.
Hematol J
. 2002 Mar;
2(4):220-7.
PMID: 11920253
Introduction: In acquired immune deficiency syndrome patients, apoptosis of uninfected lymphocytes may contribute to development of immune deficiency. This process may involve recruitment of Fas by human immunodeficiency virus products....
8.
Perno C, Cozzi-Lepri A, Balotta C, Forbici F, Violin M, Bertoli A, et al.
Antivir Ther
. 2002 Jan;
6(3):195-8.
PMID: 11808755
No abstract available.
9.
Mazzucchelli R, Corvasce S, Violin M, Riva C, Bianchi R, Deho L, et al.
J Biol Regul Homeost Agents
. 2001 Nov;
15(3):265-71.
PMID: 11693435
The finding that in addition to CD4 molecule HIV-1 uses, CCR5 or CXCR4 receptors to enter target cells prompted the research to identify polymorphisms in coreceptor genes affecting disease progression....
10.
Perno C, Cozzi-Lepri A, Balotta C, Forbici F, Violin M, Bertoli A, et al.
J Infect Dis
. 2001 Sep;
184(8):983-91.
PMID: 11574912
The role of mutations in protease (PR) and reverse-transcriptase (RT) of human immunodeficiency virus (HIV) in predicting virologic failure was assessed in 248 antiretroviral-naive HIV-positive patients who began a PR...